Innovation-Driven Venture Capital

Cross Atlantic Ventures Fund

A High-Growth Venture Capital Fund for Disruptive Industries

OVERVIEW

Fund Overview

A closed-ended venture capital fund investing in high-potential startups and scale-ups in HealthTech, and FinTech, fostering innovation and global expansion.

OVERVIEW

Fund Overview

A closed-ended venture capital fund investing in high-potential startups and scale-ups in HealthTech, and FinTech, fostering innovation and global expansion.

TARGET Fund Size

€15 Million

Fund Type

Closed-Ended Venture Capital Fund

Fund Start Date

November 2022

objective

The Cross Atlantic Ventures Fund focuses on investing in early-stage and growth-stage companies with high development potential. With a global expansion mindset, the fund provides capital to innovative businesses in key sectors such as HealthTech, and FinTech, leveraging strategic expertise to create long-term value.

STRATEGY

Fund Focus

The Cross Atlantic Ventures Fund prioritizes investments in minority stakes of high-growth startups, supporting their international expansion and innovation potential.

Enabling Growth Through Innovation

ASSET ALLOCATION

HealthTech & Life Sciences

Biotechnology & Deep Tech

FinTech & Financial Innovation

Blockchain, AI & Quantum Computing

GET TO KNOW US

Fund Focus

The Cross Atlantic Ventures Fund prioritizes investments in minority stakes of high-growth startups, supporting their international expansion and innovation potential.

Enabling
Growth Through Innovation

ASSET ALLOCATION

HealthTech & Life Sciences

Biotechnology & Deep Tech

FinTech & Financial Innovation

Blockchain, AI & Quantum Computing

PORTFOLIO

Mix of Investments

The fund strategically invests in startups and growth-stage companies with disruptive potential, ensuring diversified exposure across industries and geographies.

sectors covered

Minority Positions in Startups

Upto 100% of Portfolio

Deep Tech & Emerging Technologies

Priority Focus

Portuguese-Based Companies

Minimum 60% Allocation

Brazilian & International Expansion

Complementary Investments

FACTSHEET

FACTSHEET

Fund Highlights

The Cross Atlantic Ventures Fund is a high-growth venture capital fund, targeting innovative, early-stage companies that drive technological advancements and market disruption.

FUND TYPE

Fundo de Investimento de Capital de Risco Fechado

FUND TYPE

Fundo de Investimento de Capital de Risco Fechado

MINIMUM CAPITAL REQUIREMENT

€ 100 000

INVESTOR CATEGORY

Professional Investors

ISIN

PTEBEEHM0002

AUDITOR

Tocha, Chaves & Associados, SROC, Lda.

ISIN

PTEBEEHM0002

STAGE

Closed for New Investors

FUND TYPE

Fundo de Investimento de Capital de Risco Fechado

FUND TYPE

Fundo de Investimento de Capital de Risco Fechado

MINIMUM CAPITAL REQUIREMENT

€ 100 000

INVESTOR CATEGORY

Professional Investors

ISIN

PTEBEEHM0002

AUDITOR

Tocha, Chaves & Associados, SROC, Lda.

ISIN

PTEBEEHM0002

STAGE

Closed for New Investors

INVESTOR CATEGORY

Professional Investors

STAGE

Closed for New Investors

INVESTMENT OBJECTIVE

Invest in early-stage companies with high growth potential.

INVESTMENT OBJECTIVE

Invest in early-stage companies with high growth potential.

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

VALUATION FREQUENCY

Semiannually

DURATION

10 years, extendable for additional two-year periods

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

INVESTOR CATEGORY

Professional Investors

STAGE

Closed for New Investors

INVESTMENT OBJECTIVE

Invest in early-stage companies with high growth potential.

INVESTMENT OBJECTIVE

Invest in early-stage companies with high growth potential.

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

VALUATION FREQUENCY

Semiannually

DURATION

10 years, extendable for additional two-year periods

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

AUDITOR

Tocha, Chaves & Associados, SROC, Lda.

MINIMUM CAPITAL REQUIREMENT

€ 100 000

DURATION

10 years, extendable for additional two-year periods

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

VALUATION FREQUENCY

Semiannually

BANK

Bison Bank, SA

BANK

Bison Bank, SA

MAIL US

cavfund@octanova.pt

MAIL US

cavfund@octanova.pt

AUDITOR

Tocha, Chaves & Associados, SROC, Lda.

MINIMUM CAPITAL REQUIREMENT

€ 100 000

DURATION

10 years, extendable for additional two-year periods

INVESTMENT POLICY

Focus on Healthcare, Biotechnology, Fintechs, and Disruptive Technologies.

VALUATION FREQUENCY

Semiannually

BANK

Bison Bank, SA

BANK

Bison Bank, SA

MAIL US

cavfund@octanova.pt

MAIL US

cavfund@octanova.pt

INVESTMENT STRATEGY

INVESTMENT STRATEGY

Balanced & Strategic
Investments

Balanced & Strategic
Investments

The fund focuses on early-stage investments, supporting B2B, Deep Tech, and IP-driven startups with the potential for international scalability. The strategy ensures a balance between risk and high-reward opportunities, leveraging deep sector expertise.

The fund focuses on early-stage investments, supporting B2B, Deep Tech, and IP-driven startups with the potential for international scalability. The strategy ensures a balance between risk and high-reward opportunities, leveraging deep sector expertise.

GET IN TOUCH

Investing in the Future of Innovation

Looking to invest in high-growth startups or explore partnership opportunities? Contact us today.

Have questions about our funds, investment strategy or partnership opportunities?

We’re here to help.

TALK TO US

High-Growth Startup Portfolio

Gain access to a portfolio of high-growth startups and deep tech companies

Invest in Disruptive Sectors

Invest in disruptive sectors, including AI, blockchain, and health sciences

Support Global Business Expansion

Participate in the global expansion of innovative businesses

Connect with Venture Capital Experts

Join a network of experienced venture capital professionals

I consent to receiving communication from Octanova regarding my submitted inquiry.

By clicking submit, you agree to our Privacy Policy.

I consent to receiving communication from Octanova regarding my submitted inquiry.

By clicking submit, you agree to our Privacy Policy.